Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8 USD | +0.13% | 0.00% | +45.45% |
Apr. 19 | Nuo Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 19 | Exor-backed NUO invests in Italian teenage clothing chain Subdued | RE |
Financials (USD)
Sales 2022 | 112K | Sales 2023 | 609K | Capitalization | 24.33M |
---|---|---|---|---|---|
Net income 2022 | -3M | Net income 2023 | -3M | EV / Sales 2022 | 543 x |
Net cash position 2022 | 1.72M | Net cash position 2023 | 673K | EV / Sales 2023 | 38.9 x |
P/E ratio 2022 |
-18.9
x | P/E ratio 2023 |
-7.3
x | Employees | 9 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 40.7% |
1 day | +0.13% | ||
1 month | -15.79% | ||
3 months | +42.35% | ||
6 months | +33.33% | ||
Current year | +45.45% |
Managers | Title | Age | Since |
---|---|---|---|
David Jorden
CEO | Chief Executive Officer | 61 | 08-09-18 |
Peter Clausen
COO | Chief Operating Officer | 58 | 08-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
C. Eric Winzer
BRD | Director/Board Member | 67 | 09-01-29 |
David Jorden
CEO | Chief Executive Officer | 61 | 08-09-18 |
Paul D. Mintz
BRD | Director/Board Member | 75 | 17-04-06 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 0.8 | +0.13% | 6,384 |
24-05-07 | 0.799 | 0.00% | 2,252 |
24-05-03 | 0.799 | -0.13% | 1,702 |
Delayed Quote OTC Markets, May 08, 2024 at 03:42 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+45.45% | 35.39M | |
+2.97% | 108B | |
+10.21% | 105B | |
+1.57% | 23.46B | |
-12.77% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.50% | 17.19B | |
+6.00% | 13.99B | |
+37.20% | 12.53B |
- Stock Market
- Equities
- AURX Stock